Makon-Sébastien Njock
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Makon-Sébastien Njock has a total of 296 co-authors. Here are the top co-authors by number of shared publications:
Renaud Louis
Giga I3, Pneumology Research Group Liege University Liege Belgium
15 shared publications- Julien Guiot
Laboratory of Pneumology, GIGA Research Center, University of Liège, University Hospital of Liège, Liège, Belgium
14 shared publications Monique Henket
Laboratory of Pneumology, GIGA Research Center, University of Liège, University Hospital of Liège, Liège, Belgium
13 shared publications- Catherine Moermans
Giga I3, Pneumology Research Group, University of Liege, Liege, Belgium; Dept. of Pneumology-Allergology, CHU of Liege, Liege, Belgium
8 shared publications Fanny Gester
Laboratory of Pneumology, GIGA Research Center, University of Liège, University Hospital of Liège, Liège, Belgium
6 shared publications- Jason E. Fish
Peter Munk Cardiac Centre, UHN Research Institutes, University Health Network, Toronto, Ontario, Canada
6 shared publications
Latest Publications
- 30 March 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Mécanismes de génération des microparticules endothélialesmicroparticules endotheliales : influence du territoire vasculaire sur la capacité des cellules endothéliales à libérer les microparticules
En réponse à l'activation et/ou une apoptose, les cellules endothéliales (CE) libèrent dans le milieu environnant des microparticules endothéliales (MPE). Les microparticules sont des vésicules de petite taille résultant d'évènements membranaires liés à une perte de l'asymétrie des phospholipides. Peu de travaux concernent l'étude des mécanismes de génération des MPE et l'influence du territoire vasculaire sur la capacité de vésiculation des CE n'est pas connue. Nous avons montré que la thrombine induit la génération de MPE par un mécanisme complexe impliquant un lien entre coagulation et inflammation sur les CE macro et microvasculaires. A partir de l'étude du transcriptome, nous avons mis en évidence l'implication de TRAIL dans la génération des MPE procoagulantes par la thrombine. A l'état basal, les CE issues de différents territoires vasculaires présentent des capacités différentes de vésiculation, les CE microvasculaires présentant une plus grande capacité à libérer des MPE. L'étude du transcriptome a permis de déterminer des signatures moléculaires représentatives des territoires macro et microvasculaires. Nos travaux mettent en évidence une génération différentielle de MPE en fonction du calibre des vaisseaux et les signatures spécifiques pourraient permettre une meilleure caractérisation du territoire endothélial lésé.
- 30 March 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Mécanismes de génération des microparticules endothélialesmicroparticules endotheliales : influence du territoire vasculaire sur la capacité des cellules endothéliales à libérer les microparticules
En réponse à l'activation et/ou une apoptose, les cellules endothéliales (CE) libèrent dans le milieu environnant des microparticules endothéliales (MPE). Les microparticules sont des vésicules de petite taille résultant d'évènements membranaires liés à une perte de l'asymétrie des phospholipides. Peu de travaux concernent l'étude des mécanismes de génération des MPE et l'influence du territoire vasculaire sur la capacité de vésiculation des CE n'est pas connue. Nous avons montré que la thrombine induit la génération de MPE par un mécanisme complexe impliquant un lien entre coagulation et inflammation sur les CE macro et microvasculaires. A partir de l'étude du transcriptome, nous avons mis en évidence l'implication de TRAIL dans la génération des MPE procoagulantes par la thrombine. A l'état basal, les CE issues de différents territoires vasculaires présentent des capacités différentes de vésiculation, les CE microvasculaires présentant une plus grande capacité à libérer des MPE. L'étude du transcriptome a permis de déterminer des signatures moléculaires représentatives des territoires macro et microvasculaires. Nos travaux mettent en évidence une génération différentielle de MPE en fonction du calibre des vaisseaux et les signatures spécifiques pourraient permettre une meilleure caractérisation du territoire endothélial lésé.
- Open Access
- 6 August 2025
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 14 (8) , e70137
Inhibitors of Tax1‐PDZ Interactions Block HTLV‐1 Viral Transmission by Changing EV Composition
Extracellular vesicles (EVs) are known to facilitate infection by enveloped RNA viruses including the Human T‐cell leukemia virus type‐1 (HTLV‐1). HTLV‐1‐encoded proteins, like the transactivator and oncoprotein Tax‐1, are loaded into EVs but their precise impact on EV cargos is not yet known. Here, we report a comprehensive interaction map between Tax‐1 and the human PDZ (PSD95/DLG/ZO‐1) proteins that regulate EVs formation and composition. We show that Tax‐1 interacts with more than one‐third of hPDZome components, including proteins involved in cell cycle, cell–cell junctions, cytoskeleton organization and membrane complex assembly. We extensively characterized Tax‐1 interaction with syntenin‐1, an evolutionary conserved PDZ hub that controls EV biogenesis. Using nuclear magnetic resonance (NMR) spectroscopy, we have determined the structural basis of the interaction between the C ‐terminal PDZ binding motif of Tax‐1, and two PDZ domains of syntenin‐1. Importantly, we show that a small molecule able to inhibit HTLV‐1 cell‐to‐cell transmission breaks the Tax‐1/syntenin‐1 interaction, impacts the levels of syntenin‐1 and viral proteins in EVs, and shifts the EV composition toward cellular antiviral proteins and microRNAs, including the miR‐320 family. Consequently, we demonstrate that mimics of miR‐320c, encapsulated into EVs, have antiviral activities with a potential to be used against HTLV‐1 induced diseases.
- 6 August 2025
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 14 (8) , e70137
Open AccessInhibitors of Tax1‐PDZ Interactions Block HTLV‐1 Viral Transmission by Changing EV Composition
Extracellular vesicles (EVs) are known to facilitate infection by enveloped RNA viruses including the Human T‐cell leukemia virus type‐1 (HTLV‐1). HTLV‐1‐encoded proteins, like the transactivator and oncoprotein Tax‐1, are loaded into EVs but their precise impact on EV cargos is not yet known. Here, we report a comprehensive interaction map between Tax‐1 and the human PDZ (PSD95/DLG/ZO‐1) proteins that regulate EVs formation and composition. We show that Tax‐1 interacts with more than one‐third of hPDZome components, including proteins involved in cell cycle, cell–cell junctions, cytoskeleton organization and membrane complex assembly. We extensively characterized Tax‐1 interaction with syntenin‐1, an evolutionary conserved PDZ hub that controls EV biogenesis. Using nuclear magnetic resonance (NMR) spectroscopy, we have determined the structural basis of the interaction between the C ‐terminal PDZ binding motif of Tax‐1, and two PDZ domains of syntenin‐1. Importantly, we show that a small molecule able to inhibit HTLV‐1 cell‐to‐cell transmission breaks the Tax‐1/syntenin‐1 interaction, impacts the levels of syntenin‐1 and viral proteins in EVs, and shifts the EV composition toward cellular antiviral proteins and microRNAs, including the miR‐320 family. Consequently, we demonstrate that mimics of miR‐320c, encapsulated into EVs, have antiviral activities with a potential to be used against HTLV‐1 induced diseases.
- 8 May 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 243, 108151
High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor
- 8 May 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 243, 108151
High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor
- Open Access
- 13 February 2025
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 65 (6) , 2400276
Association of fibrotic-related extracellular vesicle microRNAs with lung involvement in systemic sclerosis
Background: There is a pressing need to identify early biomarkers of lung involvement in systemic sclerosis to start antifibrotic therapy as soon as possible. We aimed to identify extracellular vesicle-derived microRNAs (miRNAs) that are differentially expressed between systemic sclerosis patients with and without interstitial lung disease, and to explore their diagnostic value and functional properties.Methods: Small extracellular vesicles derived from plasma were isolated from 91 well-characterised patients with systemic sclerosis with (n=45) and without (n=46) interstitial lung disease and 43 matched healthy subjects. Small RNA-sequencing followed by quantitative reverse transcriptase PCR were used to identify and validate small extracellular vesicle miRNAs associated with systemic sclerosis-associated interstitial lung disease. Correlations between systemic sclerosis-associated interstitial lung disease miRNAs and clinical parameters were assessed, as well as the effect of related miRNAs/small extracellular vesicles on fibrosis.Results: We identified a four-miRNA signature associated with interstitial lung disease in the context of systemic sclerosis (miR-584-5p, miR-744-5p, miR-1307-3p and miR-10b-5p) (area under the receiver operating characteristic curve 0.85, 95% CI 0.76–0.94; p<0.0001). Deeper analysis revealed a correlation of these candidates with pulmonary function tests (diffusing capacity of the lung for carbon monoxide and forced vital capacity), highlighting their use in monitoring lung fibrosis progression in systemic sclerosis patients. Furthermore, small extracellular vesicle miRNAs associated with systemic sclerosis-associated interstitial lung disease are positively correlated with and enriched in circulating lymphocytes, suggesting that these immune cells are their cellular source. Finally, functional studies highlighted altered functional properties of small extracellular vesicles in the context of systemic sclerosis-associated interstitial lung disease, mainly due to the transfer of profibrotic miR-584-5p in lung fibroblasts.Conclusions: Our small extracellular vesicle-based biomarker approach identified a promising four‑miRNA signature characteristic of interstitial lung disease in systemic sclerosis patients. Furthermore, the profibrotic properties of small extracellular vesicles associated with systemic sclerosis-associated interstitial lung disease suggest a prominent role of these vesicles in systemic sclerosis severity.
- 13 February 2025
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 65 (6) , 2400276
Open AccessAssociation of fibrotic-related extracellular vesicle microRNAs with lung involvement in systemic sclerosis
Background: There is a pressing need to identify early biomarkers of lung involvement in systemic sclerosis to start antifibrotic therapy as soon as possible. We aimed to identify extracellular vesicle-derived microRNAs (miRNAs) that are differentially expressed between systemic sclerosis patients with and without interstitial lung disease, and to explore their diagnostic value and functional properties.Methods: Small extracellular vesicles derived from plasma were isolated from 91 well-characterised patients with systemic sclerosis with (n=45) and without (n=46) interstitial lung disease and 43 matched healthy subjects. Small RNA-sequencing followed by quantitative reverse transcriptase PCR were used to identify and validate small extracellular vesicle miRNAs associated with systemic sclerosis-associated interstitial lung disease. Correlations between systemic sclerosis-associated interstitial lung disease miRNAs and clinical parameters were assessed, as well as the effect of related miRNAs/small extracellular vesicles on fibrosis.Results: We identified a four-miRNA signature associated with interstitial lung disease in the context of systemic sclerosis (miR-584-5p, miR-744-5p, miR-1307-3p and miR-10b-5p) (area under the receiver operating characteristic curve 0.85, 95% CI 0.76–0.94; p<0.0001). Deeper analysis revealed a correlation of these candidates with pulmonary function tests (diffusing capacity of the lung for carbon monoxide and forced vital capacity), highlighting their use in monitoring lung fibrosis progression in systemic sclerosis patients. Furthermore, small extracellular vesicle miRNAs associated with systemic sclerosis-associated interstitial lung disease are positively correlated with and enriched in circulating lymphocytes, suggesting that these immune cells are their cellular source. Finally, functional studies highlighted altered functional properties of small extracellular vesicles in the context of systemic sclerosis-associated interstitial lung disease, mainly due to the transfer of profibrotic miR-584-5p in lung fibroblasts.Conclusions: Our small extracellular vesicle-based biomarker approach identified a promising four‑miRNA signature characteristic of interstitial lung disease in systemic sclerosis patients. Furthermore, the profibrotic properties of small extracellular vesicles associated with systemic sclerosis-associated interstitial lung disease suggest a prominent role of these vesicles in systemic sclerosis severity.
- Open Access
- 14 November 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (3)
The success rate and safety of induced sputum is better than you think: give it a try!
Extract Induced sputum is an easy, non-invasive, reproducible and inexpensive tool to collect cells from airways. It has been used for monitoring the airway inflammation and guide the treatment in the context of asthma with success since years and is now recognised as a gold standard in the management of severe asthma patients by the world guidelines (https://ginasthma.org).
- 14 November 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (3)
Open AccessThe success rate and safety of induced sputum is better than you think: give it a try!
Extract Induced sputum is an easy, non-invasive, reproducible and inexpensive tool to collect cells from airways. It has been used for monitoring the airway inflammation and guide the treatment in the context of asthma with success since years and is now recognised as a gold standard in the management of severe asthma patients by the world guidelines (https://ginasthma.org).
- Open Access
- 6 November 2024
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 17 (12) , 102589
Circulating inflammatory cytokines predict severity disease in hospitalized COVID-19 patients: A prospective multicenter study of the European DRAGON consortium
- 6 November 2024
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 17 (12) , 102589
Open AccessCirculating inflammatory cytokines predict severity disease in hospitalized COVID-19 patients: A prospective multicenter study of the European DRAGON consortium
- Open Access
- 26 September 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (19) , 2136
Long Term Evaluation of Quantitative Cumulative Irradiation in Patients Suffering from ILDs
Background: Interstitial lung diseases (ILDs) are an heterogeneous group of infiltrating lung pathologies, for which prompt diagnosis and continuous assessment are of paramount importance. While chest CT is an established diagnostic tool for ILDs, there are no formal guidelines on the follow-up regimen, leaving the frequency and modality of follow-up largely at the clinician’s discretion. Methods: The study retrospectively evaluated the indication of chest CT in a cohort of 129 ILD patients selected from the ambulatory care polyclinic at University Hospital of Liège. The aim was to determine whether the imagining acquisition had a true impact on clinical course and follow-up. We accepted three different situations for justifying the indication of the CTs: clinical deterioration, a decrease in pulmonary function tests (at least a 10% drop in a parameter), and monitoring for oncological purposes. The other indications, mainly routine follow-up, were classified as “non-justified”. Radiation dose output was evaluated with Computed Tomography Dose Index (CTDI) and Dose Length Product (DLP). Results: The mean number of CT scans per patient per year was 1.7 ± 0.4, determining irradiation in CTDI (mGy)/year of 34.9 ± 64.9 and DLP in (mGy*cm)/year of 1095 ± 1971. The percentage of justified CT scans was 57 ± 32%, while the scans justified a posteriori were 60 ± 34%. Around 40% of the prescribed monitoring CT scans had no impact on the management of ILD and direct patient care. Conclusions: Our study identifies a trend of overuse in chest CT scans at follow-up (up to 40%), outside those performed for clinical exacerbation or oncological investigation. In the particular case of ILD exacerbation, CT scan value remains high, underlying the benefit of this strategy.
- 26 September 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (19) , 2136
Open AccessLong Term Evaluation of Quantitative Cumulative Irradiation in Patients Suffering from ILDs
Background: Interstitial lung diseases (ILDs) are an heterogeneous group of infiltrating lung pathologies, for which prompt diagnosis and continuous assessment are of paramount importance. While chest CT is an established diagnostic tool for ILDs, there are no formal guidelines on the follow-up regimen, leaving the frequency and modality of follow-up largely at the clinician’s discretion. Methods: The study retrospectively evaluated the indication of chest CT in a cohort of 129 ILD patients selected from the ambulatory care polyclinic at University Hospital of Liège. The aim was to determine whether the imagining acquisition had a true impact on clinical course and follow-up. We accepted three different situations for justifying the indication of the CTs: clinical deterioration, a decrease in pulmonary function tests (at least a 10% drop in a parameter), and monitoring for oncological purposes. The other indications, mainly routine follow-up, were classified as “non-justified”. Radiation dose output was evaluated with Computed Tomography Dose Index (CTDI) and Dose Length Product (DLP). Results: The mean number of CT scans per patient per year was 1.7 ± 0.4, determining irradiation in CTDI (mGy)/year of 34.9 ± 64.9 and DLP in (mGy*cm)/year of 1095 ± 1971. The percentage of justified CT scans was 57 ± 32%, while the scans justified a posteriori were 60 ± 34%. Around 40% of the prescribed monitoring CT scans had no impact on the management of ILD and direct patient care. Conclusions: Our study identifies a trend of overuse in chest CT scans at follow-up (up to 40%), outside those performed for clinical exacerbation or oncological investigation. In the particular case of ILD exacerbation, CT scan value remains high, underlying the benefit of this strategy.
- Open Access
- 1 September 2023
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1277909
Editorial: Progressive fibrosing interstitial lung disease: from bench to bedside
Editorial: Progressive fibrosing interstitial lung disease: from bench to bedside
- 1 September 2023
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1277909
Open AccessEditorial: Progressive fibrosing interstitial lung disease: from bench to bedside
Editorial: Progressive fibrosing interstitial lung disease: from bench to bedside
- Open Access
- 24 July 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (31)
The helicase-like transcription factor redirects the autophagic flux and restricts human T cell leukemia virus type 1 infection
Retroviruses and their host have coevolved in a delicate balance between viral replication and survival of the infected cell. In this equilibrium, restriction factors expressed by infected cells control different steps of retroviral replication such as entry, uncoating, nuclear import, expression, or budding. Here, we describe a mechanism of restriction against human T cell leukemia virus type 1 (HTLV-1) by the helicase-like transcription factor (HLTF). We show that RNA and protein levels of HLTF are reduced in primary T cells of HTLV-1-infected subjects, suggesting a clinical relevance. We further demonstrate that the viral oncogene Tax represses HLTF transcription via the Enhancer of zeste homolog 2 methyltransferase of the Polycomb repressive complex 2. The Tax protein also directly interacts with HLTF and induces its proteasomal degradation. RNA interference and gene transduction in HTLV-1-infected T cells derived from patients indicate that HLTF is a restriction factor. Restoring the normal levels of HLTF expression induces the dispersal of the Golgi apparatus and overproduction of secretory granules. By synergizing with Tax-mediated NF-κB activation, physiologically relevant levels of HLTF intensify the autophagic flux. Increased vesicular trafficking leads to an enlargement of the lysosomes and the production of large vacuoles containing viral particles. HLTF induction in HTLV-1-infected cells significantly increases the percentage of defective virions. In conclusion, HLTF-mediated activation of the autophagic flux blunts the infectious replication cycle of HTLV-1, revealing an original mode of viral restriction.
- 24 July 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (31)
Open AccessThe helicase-like transcription factor redirects the autophagic flux and restricts human T cell leukemia virus type 1 infection
Retroviruses and their host have coevolved in a delicate balance between viral replication and survival of the infected cell. In this equilibrium, restriction factors expressed by infected cells control different steps of retroviral replication such as entry, uncoating, nuclear import, expression, or budding. Here, we describe a mechanism of restriction against human T cell leukemia virus type 1 (HTLV-1) by the helicase-like transcription factor (HLTF). We show that RNA and protein levels of HLTF are reduced in primary T cells of HTLV-1-infected subjects, suggesting a clinical relevance. We further demonstrate that the viral oncogene Tax represses HLTF transcription via the Enhancer of zeste homolog 2 methyltransferase of the Polycomb repressive complex 2. The Tax protein also directly interacts with HLTF and induces its proteasomal degradation. RNA interference and gene transduction in HTLV-1-infected T cells derived from patients indicate that HLTF is a restriction factor. Restoring the normal levels of HLTF expression induces the dispersal of the Golgi apparatus and overproduction of secretory granules. By synergizing with Tax-mediated NF-κB activation, physiologically relevant levels of HLTF intensify the autophagic flux. Increased vesicular trafficking leads to an enlargement of the lysosomes and the production of large vacuoles containing viral particles. HLTF induction in HTLV-1-infected cells significantly increases the percentage of defective virions. In conclusion, HLTF-mediated activation of the autophagic flux blunts the infectious replication cycle of HTLV-1, revealing an original mode of viral restriction.